检索结果 - Tara C. Rubinas

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Inter- and Intraobserver Reliability and Validation of a New Method for Determination of Eosinophil Counts in Patients with Esophageal Eosinophilia

    Inter- and Intraobserver Reliability and Validation of a New Method for Determination of Eosinophil Counts in Patients with Esophageal Eosinophilia 由 Evan S. Dellon, Karen Fritchie, Tara C. Rubinas, John T. Woosley, Nicholas J. Shaheen

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility

    Modulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility 由 Joshua M. Uronis, Marcus Mühlbauer, Hans Herfarth, Tara C. Rubinas, Gieira S. Jones, Christian Jobin

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Cutting Edge: IFN-γ Is a Negative Regulator of IL-23 in Murine Macrophages and Experimental Colitis

    Cutting Edge: IFN-γ Is a Negative Regulator of IL-23 in Murine Macrophages and Experimental Colitis 由 Shehzad Z. Sheikh, Katsuyoshi Matsuoka, Taku Kobayashi, Fengling Li, Tara C. Rubinas, Scott E. Plevy

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Tryptase Staining of Mast Cells May Differentiate Eosinophilic Esophagitis from Gastroesophageal Reflux Disease

    Tryptase Staining of Mast Cells May Differentiate Eosinophilic Esophagitis from Gastroesophageal Reflux Disease 由 Evan S. Dellon, Xiaoxin Chen, C. Ryan Miller, Karen Fritchie, Tara C. Rubinas, John T. Woosley, Nicholas J. Shaheen

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Clinical, Endoscopic, and Histologic Findings Distinguish Eosinophilic Esophagitis From Gastroesophageal Reflux Disease

    Clinical, Endoscopic, and Histologic Findings Distinguish Eosinophilic Esophagitis From Gastroesophageal Reflux Disease 由 Evan S. Dellon, Wood Gibbs, Karen Fritchie, Tara C. Rubinas, Lindsay A. Wilson, John T. Woosley, Nicholas J. Shaheen

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    <i>KRAS/BRAF</i> mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer

    <i>KRAS/BRAF</i> mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer 由 Jen Jen Yeh, Elizabeth D. Routh, Tara C. Rubinas, Janie Peacock, Timothy D. Martin, Xiang Shen, Robert S. Sandler, Han Jo Kim, Temitope O. Keku, Channing J. Der

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: